Beijing Errui Xinyue raises US$4.13M in Series A extension

What's the deal? Beijing Errui Xinyue Technology has raised US$4.13M (roughly US$4.5 million) in a Series A extension round, announced in August 2026.

What it does. The company develops early-diagnosis technology and products for neurodegenerative diseases, with a focus on exosome-related research and applications.

Why now? The funding supports continued technology development and product innovation in life sciences.

Read more: ITJuZi